TrialInvestigational new drugs2014

Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancer.

Emiliano Calvo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.